Search Medical Condition
Please enter condition
Please choose location from dropdown
 

Odenwald, Erbach Clinical Trials

A listing of Odenwald, Erbach clinical trials actively recruiting patients volunteers.

RESULTS

Found (1) clinical trials

Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS)

This is a prospective, multicenter, open-label, single-arm, phase 3b study which evaluates effectiveness and safety of ocrelizumab in participants with early stage RRMS. The study will consist of an open-label treatment period of 192 weeks and follow-up period of at least 48 weeks.

Phase